Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02193932 · ClinicalTrials.gov registry record · NA
Electroencephalogram (EEG) Triggered Functional Magnetic Resonance Imaging (fMRI) in Epilepsy Patients
A NA study, sponsored by Baptist Health South Florida.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02193932 is a NA study that has completed, run by Baptist Health South Florida. The registered enrollment target is 2 participants.
The verdict
NCT02193932, a NA study, has completed, sponsored by Baptist Health South Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
A prospective exploratory study in patients with drug resistant epilepsy with a target comparison of long term outcome. NeuroScan software modules and a MagLink will be used to acquire EEG in combination with MRI/fMRI data. The MagLink system is used for obtaining integrated EEG and Event Related Potential (ERP) recordings while the subject is inside the MRI machine, without compromising the raw EEG data.
Interventions
- OTHER EEG Triggered fMRI using Micro Maglink
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2013-02-01 |
| Est. Completion | 2019-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02193932
The ClinicalTrials.gov registry entry for NCT02193932 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baptist Health South Florida, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EEG Triggered fMRI using Micro Maglink is the first listed.
NCT02193932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02193932 about?
NCT02193932 is a clinical study titled "Electroencephalogram (EEG) Triggered Functional Magnetic Resonance Imaging (fMRI) in Epilepsy Patients". A prospective exploratory study in patients with drug resistant epilepsy with a target comparison of long term outcome. NeuroScan software modules and a MagLink will be used to acquire EEG in combination with MRI/fMRI data. The MagLink system is used for obtaining integrated EEG and Event Related Po...
What is the current status of trial NCT02193932?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2013-02-01. Estimated completion is 2019-07-30.
What interventions are being tested in trial NCT02193932?
The interventions under investigation include: EEG Triggered fMRI using Micro Maglink (OTHER).
Who is sponsoring clinical trial NCT02193932?
This trial is sponsored by Baptist Health South Florida, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.